ISSN: 1743-5889

Journal Home

Journal Guideline

Nanomedicine Q1 Unclaimed

Future Medicine Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nanomedicine is a journal indexed in SJR in Medicine (miscellaneous) and Development with an H index of 127. It has an SJR impact factor of 0,695 and it has a best quartile of Q1. It has an SJR impact factor of 0,695.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Development (Q1) Bioengineering (Q2) Biomedical Engineering (Q2) Materials Science (miscellaneous) (Q2) Medicine (miscellaneous) (Q2) Nanoscience and Nanotechnology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,695

SJR Impact factor

127

H Index

125

Total Docs (Last Year)

597

Total Docs (3 years)

8875

Total Refs

2882

Total Cites (3 years)

556

Citable Docs (3 years)

4.32

Cites/Doc (2 years)

71

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1

Compare this journals

Aims and Scope

Best articles by citations

Nanostructured titanium: the ideal material for improving orthopedic implant efficacy?

Biomedical applications of gold nanomaterials

Mucoadhesive nanogels by ionotropic crosslinking of chitosan-g-oligo(NiPAam) polymeric micelles as novel drug nanocarriers

Highlights from the latest articles in gold nanoparticles for theranostics

Nanotargeted agents: an emerging therapeutic strategy for breast cancer

Colloidal nanomaterial-based immunoassay

PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma

Nanoparticle aerosols: boon or bane for breathing?

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders

Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a Quality by Design-driven perspective

Molecular plasmonics for biology and nanomedicine

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors

SHOW MORE ARTICLES

Research Highlights

Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers:in vitroandin vivoeffects

Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines

Nanotechnology in bladder cancer: current state of development and clinical practice

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting

Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties andin vivobehavior

Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression

Research Highlights

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites

Research Highlights

Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells

Research Highlights

Nanomedicine Q1 Unclaimed

- €

NPD

- €

Metrics

0,695

127

125

597

8875

2882

556

4.32

71

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Nanomedicine?